The Neuroprotective Role of Neuroserpin in Ischemic and Hemorrhagic Stroke

Overview

Journal Curr Neuropharmacol

Publisher Bentham Science Publishers

Date 2020 Oct 9

PMID 33032511

Citations 7

Authors

Shanshan Ding

QiLiang Chen

Huaqin Chen

Bangshui Luo

Candong Li

Liang Wang

Tetsuya Asakawa

Affiliations

Soon will be listed here.

Abstract

Tissue plasminogen activator (tPA) is commonly used to treat acute ischemic stroke within an appropriate therapeutic window. Its inhibitor, neuroserpin (NSP), is reported to exhibit neuroprotective effects on stroke. This review aims to summarize, from literature, the available evidence, potential mechanisms, and knowledge limitations regarding the neuroprotective role of NSP in stroke. All the available evidence indicates that the regulation of the inflammatory response may play a key role in the mechanisms of NSP, which involve all the constituents of the neuroimmune axis. The neuroinflammatory response triggered by stroke can be reversed by NSP, with complicated mechanisms such as maintenance and reconstruction of the structure and function of the blood-brain barrier (BBB), protection of the cells in the central nervous system, and suppression of cell death in both ischemic and hemorrhagic stroke. Moreover, available evidence strongly suggests a tPA-independent mechanism is involved in NSP. However, there are many important issues that are still unclear and need further investigation, such as the effects of NSP on hemorrhagic stroke, the role of the tPA-independent neuroprotective mechanisms, and the clinical application prospects of NSP. We believe our work will be helpful to further understand the neuroprotective role of NSP.

Citing Articles

The development of anti-PD-1 antibody-induced spinal cord injury in bone marrow transplant C57BL/6 mouse model.

Chen H, Lu Z, Ni X, Zhang H, Chen G, Wu X Immunotherapy. 2024; 16(14-15):975-985.

PMID: 39115961 PMC: 11486090. DOI: 10.1080/1750743X.2024.2383557.

Neuroserpin normalization by mesenchymal stem cell therapy after encephalopathy of prematurity in neonatal rats.

Wang L, Hsiung C, Chang C, Lin M, Chen S Pediatr Res. 2024; .

PMID: 39085403 DOI: 10.1038/s41390-024-03412-z.

Neural Stem Cell-Derived Small Extracellular Vesicles: key Players in Ischemic Stroke Therapy - A Comprehensive Literature Review.

Zhu Z, Zhang Q, Feng J, Zebaze Dongmo S, Zhang Q, Huang S Int J Nanomedicine. 2024; 19:4279-4295.

PMID: 38766658 PMC: 11102074. DOI: 10.2147/IJN.S451642.

The probable role of tissue plasminogen activator/neuroserpin axis in Alzheimer's disease: a new perspective.

Ali N, Al-Kuraishy H, Al-Gareeb A, Alnaaim S, Alexiou A, Papadakis M Acta Neurol Belg. 2023; 124(2):377-388.

PMID: 37917293 PMC: 10965687. DOI: 10.1007/s13760-023-02403-x.

Serpin family proteins as potential biomarkers and therapeutic drugs in stroke: A systematic review and meta-analysis on clinical/preclinical studies.

Yan B, Luo L, Liu L, Wang Z, Chen R, Wu Y CNS Neurosci Ther. 2023; 29(7):1738-1749.

PMID: 37017398 PMC: 10324362. DOI: 10.1111/cns.14205.

References

Macleod M, van der Worp H, Sena E, Howells D, Dirnagl U, Donnan G . Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke. 2008; 39(10):2824-9. DOI: 10.1161/STROKEAHA.108.515957. View

Ma J, Tong Y, Yu D, Mao M . Tissue plasminogen activator-independent roles of neuroserpin in the central nervous system. Neural Regen Res. 2015; 7(2):146-51. PMC: 4354132. DOI: 10.3969/j.issn.1673-5374.2012.02.012. View

Li Z, Pang L, Fang F, Zhang G, Zhang J, Xie M . Resveratrol attenuates brain damage in a rat model of focal cerebral ischemia via up-regulation of hippocampal Bcl-2. Brain Res. 2012; 1450:116-24. DOI: 10.1016/j.brainres.2012.02.019. View

Pardridge W . Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev. 1983; 63(4):1481-535. DOI: 10.1152/physrev.1983.63.4.1481. View

Li W, Asakawa T, Han S, Xiao B, Namba H, Lu C . Neuroprotective effect of neuroserpin in non-tPA-induced intracerebral hemorrhage mouse models. BMC Neurol. 2017; 17(1):196. PMC: 5688810. DOI: 10.1186/s12883-017-0976-1. View

Zhao J, Liu Z, Wang B, Huang T, Guo D, Zhao Y . Inhibiting endogenous tissue plasminogen activator enhanced neuronal apoptosis and axonal injury after traumatic brain injury. Neural Regen Res. 2019; 15(4):667-675. PMC: 6975145. DOI: 10.4103/1673-5374.266914. View

Wolburg H, Lippoldt A . Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul Pharmacol. 2003; 38(6):323-37. DOI: 10.1016/s1537-1891(02)00200-8. View

Jiang J, Dai J, Cui H . Vitexin reverses the autophagy dysfunction to attenuate MCAO-induced cerebral ischemic stroke via mTOR/Ulk1 pathway. Biomed Pharmacother. 2018; 99:583-590. DOI: 10.1016/j.biopha.2018.01.067. View

Lee T, Tsang V, Loef E, Birch N . Physiological and pathological functions of neuroserpin: Regulation of cellular responses through multiple mechanisms. Semin Cell Dev Biol. 2016; 62:152-159. DOI: 10.1016/j.semcdb.2016.09.007. View

10.

Wang C, Jie C, Dai X . Possible roles of astrocytes in estrogen neuroprotection during cerebral ischemia. Rev Neurosci. 2014; 25(2):255-68. DOI: 10.1515/revneuro-2013-0055. View

11.

Lebeurrier N, Liot G, Lopez-Atalaya J, Orset C, Fernandez-Monreal M, Sonderegger P . The brain-specific tissue-type plasminogen activator inhibitor, neuroserpin, protects neurons against excitotoxicity both in vitro and in vivo. Mol Cell Neurosci. 2005; 30(4):552-8. DOI: 10.1016/j.mcn.2005.09.005. View

12.

Jiang B, Yang W, Chen L, Wang S, Chen S, Bao Y . In vitro effects of Pueraria extract on ethanol-exposed microglia and neurons. Biomed Pharmacother. 2020; 127:110163. DOI: 10.1016/j.biopha.2020.110163. View

13.

Munuswamy-Ramanujam G, Dai E, Liu L, Shnabel M, Sun Y, Bartee M . Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets. Thromb Haemost. 2010; 103(3):545-55. DOI: 10.1160/TH09-07-0441. View

14.

Wang L, Zhang Y, Asakawa T, Li W, Han S, Li Q . Neuroprotective effect of neuroserpin in oxygen-glucose deprivation- and reoxygenation-treated rat astrocytes in vitro. PLoS One. 2015; 10(4):e0123932. PMC: 4395230. DOI: 10.1371/journal.pone.0123932. View

15.

Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P . Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation. 2002; 106(6):740-5. DOI: 10.1161/01.cir.0000023942.10849.41. View

16.

Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao C . Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci. 2002; 18(5):443-57. DOI: 10.1006/mcne.2001.1028. View

17.

Asakawa T, Zong L, Wang L, Xia Y, Namba H . Unmet challenges for rehabilitation after stroke in China. Lancet. 2017; 390(10090):121-122. DOI: 10.1016/S0140-6736(17)31584-2. View

18.

Zozulya A, Weidenfeller C, Galla H . Pericyte-endothelial cell interaction increases MMP-9 secretion at the blood-brain barrier in vitro. Brain Res. 2007; 1189:1-11. DOI: 10.1016/j.brainres.2007.10.099. View

19.

Lochhead J, McCaffrey G, Quigley C, Finch J, Demarco K, Nametz N . Oxidative stress increases blood-brain barrier permeability and induces alterations in occludin during hypoxia-reoxygenation. J Cereb Blood Flow Metab. 2010; 30(9):1625-36. PMC: 2949263. DOI: 10.1038/jcbfm.2010.29. View

20.

Lemarchant S, Docagne F, Emery E, Vivien D, Ali C, Rubio M . tPA in the injured central nervous system: different scenarios starring the same actor?. Neuropharmacology. 2011; 62(2):749-56. DOI: 10.1016/j.neuropharm.2011.10.020. View